SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-057545
Filing Date
2022-05-09
Accepted
2022-05-09 16:18:54
Documents
1
Period of Report
2022-05-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2214815-12_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2214815-12_4seq1.xml 4 4628
  Complete submission text file 0001104659-22-057545.txt   6124
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Issuer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GELESIS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address
Sannino Alessandro (Reporting) CIK: 0001895699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39362 | Film No.: 22905251